Switching to DTG/3TC fixed-dose combination (FDC) Is non-inferior to continuing a TAF-based regimen in maintaining virologic suppression through 48 weeks (TANGO Study)
Saved in:
Main Authors: | J. Van Wyk (Author), F. Ajana (Author), F. Bisshop (Author), S. De Wit (Author), Y. Osiyemi (Author), J. Portilla (Author), J. Routy (Author), C. Wyen (Author), M. Ait-Khaled (Author), M. Nascimento (Author), K. Pappa (Author), R. Wang (Author), J. Wright (Author), A. Tenorio (Author), B. Wynne (Author), M. Aboud (Author), M. Gartland (Author), K. Smith (Author), Y. El-Bahy (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Durable Efficacy of Dolutegravir (DTG) Plus Lamivudine (3TC) in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI Studies
by: P. Cahn, et al.
Published: (2020) -
Reseña a Un tango con la muerte
by: Francisco J. Quevedo García
Published: (2016) -
Exercícios alternativos para a TAF
by: José Freire Lima
Published: (1993) -
Tango: atração e relutância
by: Ester Buffa
Published: (2020) -
Tango Lessons Movement, Sound, Image, and Text in Contemporary Practice
Published: (2014)